Asia Pacific Cell Reprogramming Market Size & Outlook
Asia Pacific cell reprogramming market, 2018-2030 (US$M)
Related Markets
Asia Pacific cell reprogramming market highlights
- The Asia Pacific cell reprogramming market generated a revenue of USD 93.8 million in 2023.
- The market is expected to grow at a CAGR of 8.9% from 2024 to 2030.
- In terms of segment, mrna reprogramming was the largest revenue generating technology in 2023.
- MRNA Reprogramming is the most lucrative technology segment registering the fastest growth during the forecast period.
- Country-wise, China is expected to register the highest CAGR from 2024 to 2030.
Asia Pacific data book summary
| Market revenue in 2023 | USD 93.8 million |
| Market revenue in 2030 | USD 169.9 million |
| Growth rate | 8.9% (CAGR from 2023 to 2030) |
| Largest segment | Mrna reprogramming |
| Fastest growing segment | MRNA Reprogramming |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Sendai Virus-based Reprogramming, MRNA Reprogramming, Episomal Reprogramming |
| Key market players worldwide | Thermo Fisher Scientific Inc, Merck KGaA, Bio-Techne Corp, ReproCELL, Lonza Group Ltd, FUJIFILM Holdings Corp, Astellas Pharma Inc, Allele Biotech, Alstem, STEMCELL Technologies |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 25.0% of the global cell reprogramming market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 169.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cell Reprogramming Market Scope
Cell Reprogramming Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific cell reprogramming market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cell reprogramming market will help companies and investors design strategic landscapes.
Mrna reprogramming was the largest segment with a revenue share of 31.88% in 2023. Horizon Databook has segmented the Asia Pacific cell reprogramming market based on sendai virus-based reprogramming, mrna reprogramming, episomal reprogramming covering the revenue growth of each sub-segment from 2018 to 2030.
- Asia Pacific Cell Reprogramming Technology Outlook (Revenue, USD Million, 2018-2030)
- Sendai Virus-based Reprogramming
- mRNA Reprogramming
- Episomal Reprogramming
- Others
- Asia Pacific Cell Reprogramming Application Outlook (Revenue, USD Million, 2018-2030)
- Research
- Therapeutic
- Asia Pacific Cell Reprogramming End Use Outlook (Revenue, USD Million, 2018-2030)
- Research & Academic Institutes
- Biotechnology & Pharmaceutical Companies
Reasons to subscribe to Asia Pacific cell reprogramming market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific cell reprogramming market databook
-
Our clientele includes a mix of cell reprogramming market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific cell reprogramming market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific cell reprogramming market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific cell reprogramming market size, by country, 2018-2030 (US$M)
Asia Pacific Cell Reprogramming Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
